Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 1,267 results.

Thumbnail for Prognostic Impact of Interphase FISH in Multiple Myeloma: Single-Center Irish Experience

MM - 082

Prognostic Impact of Interphase FISH in Multiple Myeloma: Single-Center Irish Experience

Tushar Pramod

Poster Presenter: Tushar Pramod

Thumbnail for Cardiovascular and Infectious Toxicities Associated With Targeted Therapies in Chronic Lymphocytic Leukemia

CLL - 083

Cardiovascular and Infectious Toxicities Associated With Targeted Therapies in Chronic Lymphocytic Leukemia

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

Thumbnail for Have Survival Gains in Acute Myeloid Leukemia Been Equitable? Persistent Racial Disparities in a SEER Analysis (2000-2023)

Previous 1...5 6 7 8 9 10 11...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

AML - 085

Have Survival Gains in Acute Myeloid Leukemia Been Equitable? Persistent Racial Disparities in a SEER Analysis (2000-2023)

Edward Mwarangu

Poster Presenter: Edward Mwarangu

$Thumbnail for Trial in Progress (IGNITE): A Phase 3, Multiregional, Open-Label, Randomized Study of Tirabrutinib vs Rituximab and Temozolomide (RTX-TMZ) in Relapsed/Refractory (R/R) Primary Central Nervous System Lymphoma (PCNSL)$

ABCL - 086

Trial in Progress (IGNITE): A Phase 3, Multiregional, Open-Label, Randomized Study of Tirabrutinib vs Rituximab and Temozolomide (RTX-TMZ) in Relapsed/Refractory (R/R) Primary Central Nervous System Lymphoma (PCNSL)

Lakshmi Nayak

Poster Presenter: Lakshmi Nayak

Thumbnail for Nationwide Trends in Acute Myeloid Leukemia Mortality Arising From Philadelphia Chromosome-Negative Myeloproliferative Neoplasms in the United States, 1999-2023

AML - 087

Nationwide Trends in Acute Myeloid Leukemia Mortality Arising From Philadelphia Chromosome-Negative Myeloproliferative Neoplasms in the United States, 1999-2023

Valerin Arno Encarnacion

Poster Presenter: Valerin Arno Encarnacion

Thumbnail for Survival Outcomes and Racial Disparities in Adolescent and Young Adult Classic Philadelphia-Negative Myeloproliferative Neoplasms: A SEER Analysis, 2000-2023

MPN - 088

Survival Outcomes and Racial Disparities in Adolescent and Young Adult Classic Philadelphia-Negative Myeloproliferative Neoplasms: A SEER Analysis, 2000-2023

Edward Mwarangu

Poster Presenter: Edward Mwarangu

Thumbnail for Is IgA Isotype an Independent Adverse Prognostic Factor in Multiple Myeloma? A Systematic Review and Meta-Analysis of Cytogenetic Risk, Survival, and Treatment Outcomes in the Modern Era

MM - 089

Is IgA Isotype an Independent Adverse Prognostic Factor in Multiple Myeloma? A Systematic Review and Meta-Analysis of Cytogenetic Risk, Survival, and Treatment Outcomes in the Modern Era

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

CML - 090

Real-World Data on Clinical Profile, Treatment Strategies, and Feto-Maternal Outcomes of Pregnancies Among Patients With Chronic Myeloid Leukemia in a Resource-Constrained Setting: A 5-Year Single-Center Retrospective Cohort Study

Caryn Louise Gutierrez

Poster Presenter: Caryn Louise Gutierrez

Thumbnail for Survival and Early Mortality Disparities in Classical Hodgkin Lymphoma Across the Immunotherapy Era: A SEER Analysis (2010-2022)

HL - 092

Survival and Early Mortality Disparities in Classical Hodgkin Lymphoma Across the Immunotherapy Era: A SEER Analysis (2010-2022)

Edward Mwarangu

Poster Presenter: Edward Mwarangu

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors